The type segmentation classifies devices by technology and design, directly influencing market valuation. Conventional (2‑D) ultrasound systems remain the workhorse, capturing the bulk of sales due to their established clinical utility, cost‑effectiveness, and broad adoption across hospitals and outpatient clinics. Advanced modalities—including 3‑D/4‑D, Doppler, and elastography—capture premium pricing and represent a growing share as clinicians demand enhanced diagnostic detail, especially in cardiology and obstetrics. Portable and handheld units, a fast‑growing niche, address point‑of‑care needs, offering lower acquisition costs and flexibility, thereby expanding market penetration in emerging economies and remote settings. Specialized therapeutic devices, such as high‑intensity focused ultrasound (HIFU) and physiotherapy units, constitute a smaller but high‑margin segment, reflecting targeted clinical applications. Together, these type categories define the market taxonomy, with conventional systems providing volume, advanced and portable solutions delivering growth, and specialized therapeutic devices adding niche value.